SRDAPRT.BO(SRDAPRT.BO)
SRDAPRT.BO
$136.86—Stale · unknown old
BSE • Last print unknown ago
$136.86—Stale · unknown old
Sarda Proteins Ltd. specializes in the production of protein-based agricultural inputs, primarily serving the Indian market. The company differentiates itself through its proprietary formulations and strong relationships with local farmers, which enhance customer loyalty and market penetration.
Sarda Proteins generates revenue through the sale of specialized protein supplements and fertilizers, leveraging its proprietary formulations to command premium pricing. The company benefits from low debt levels (Debt/Equity of 0.05), allowing for competitive pricing strategies while maintaining healthy margins despite a low gross margin of 4.0%.
Fluctuations in raw material prices, particularly soy and corn, which directly impact production costs
Changes in agricultural policy and subsidies in India that affect farmer spending
Market demand for protein supplements driven by livestock production trends
Seasonal weather patterns affecting crop yields and livestock health
Regulatory changes impacting agricultural practices and input usage
Technological advancements in alternative protein sources that could reduce demand
Emerging local competitors offering lower-priced alternatives
Global suppliers entering the Indian market with established brands
Negative cash flow impacting operational flexibility
High price-to-book ratio (29.1x) indicating potential overvaluation
moderate - The agricultural inputs sector is somewhat insulated from economic downturns, but overall demand can be affected by GDP growth and consumer spending in the agricultural sector.
Interest rates have minimal direct impact on Sarda Proteins, given its low debt levels. However, rising rates could affect farmer borrowing costs, potentially reducing demand for inputs.
minimal - The company operates with very low debt, reducing its exposure to credit market fluctuations.
value - Investors may be drawn to the low Price/Sales ratio (0.9x) despite current operational challenges.
high - The stock has exhibited significant price fluctuations, evidenced by a 1-Year return of -32.2%.